ARCHIVES

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Harold Varmus Addresses the NCI Board of Scientific Advisors

March 8, 2013

Funding Opportunity: DOD Devotes $150 Million to Breast Cancer Research

August 5, 2011

NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology

December 6, 1996

NCI to Expand Quality of Care Research, Lead HHS Panel On Cancer Care Policy.

October 1, 1999

In Brief: Cancer Program Get Shot In Arm With Override Of Appropriations Vet; Carter To Leave NCI

February 6, 1976